Document Detail


Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia.
MedLine Citation:
PMID:  1829005     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Platelet monoamine oxidase (MAO) activity has previously been shown to be increased in patients with senile dementia of Alzheimer type (SDAT) and in patients with megaloblastic anaemia. Moreover, low serum B12 levels were found to be 4-5 times more frequent in SDAT compared with an unselected population of similar age. In the present investigation, platelet MAO activity was estimated in 14 SDAT patients with relatively low serum B12 levels and in 4 patients with pernicious anaemia. Before B12 therapy, platelet MAO activity was significantly increased in both patient groups compared with a control group. After B12 therapy, platelet MAO activity was significantly reduced in both patient groups to apparently normal levels. The present results show that B12 status is a controlling factor of platelet MAO activity and confirm that a significant connection exists between vitamin B12 deficiency and primary degenerative dementia disorders, such as SDAT.
Authors:
B Regland; C G Gottfries; L Oreland
Related Documents :
345825 - Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of ...
9493325 - Bioconcentration of chlorinated biphenyls in biota from the north pacific ocean.
239905 - Spasmolytic activity of two synthetic anilide local anaesthetics.
9251725 - Lack of evidence for the involvement of formaldehyde in the hepatocarcinogenicity of me...
622565 - L-dopa methyl ester: prolongation of survival of neuroblastoma-bearing mice after treat...
2731595 - Radiolabelling of human platelets with 99mtc-hmpao.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European archives of psychiatry and clinical neuroscience     Volume:  240     ISSN:  0940-1334     ISO Abbreviation:  Eur Arch Psychiatry Clin Neurosci     Publication Date:  1991  
Date Detail:
Created Date:  1991-08-01     Completed Date:  1991-08-01     Revised Date:  2009-05-11    
Medline Journal Info:
Nlm Unique ID:  9103030     Medline TA:  Eur Arch Psychiatry Clin Neurosci     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  288-91     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, St. Jörgen's Hospital, University of Gothenburg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Alzheimer Disease / enzymology*
Anemia, Pernicious / drug therapy,  enzymology*
Blood Platelets / drug effects,  enzymology*
Female
Humans
Hydroxocobalamin / administration & dosage*
Injections, Intramuscular
Male
Monoamine Oxidase / blood*
Vitamin B 12 / blood
Vitamin B 12 Deficiency / drug therapy,  enzymology*
Chemical
Reg. No./Substance:
13422-51-0/Hydroxocobalamin; 68-19-9/Vitamin B 12; EC 1.4.3.4/Monoamine Oxidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Computer-assisted attention training in schizophrenics. A comparative study.
Next Document:  The predictability of relapses in schizophrenic patients.